$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > TALAPRO-2

恩扎卢胺|最新研究

TALAPRO-2研究前列腺癌患者报告结局、药物暴露量与安全性及生活
TALAPRO-2研究:PARP抑制剂talazoparib联合恩扎卢胺一线治疗转移

恩扎卢胺|上市信息

FDA批准他拉唑帕利联合恩扎卢胺上市,一线治疗HRR突变转移性去势抵